quirem.com
About company
Quirem Medical is a healthcare firm specializing in the development of next-generation microspheres for Selective Internal Radiation Therapy (SIRT), a treatment for liver tumors. Quirem Medical develops and commercializes the next-generation Selective Internal Radiation Therapy (SIRT) microspheres based on the radioisotope Holmium-166. The company believes the treatment outcome of unresectable liver cancer with SIRT can be optimized with Holmium-166 microspheres, which can be visualized and quantified to improve SIRT patient selection, treatment planning and treatment verification. Its innovative Holmium-166 platform technology provides physicians a complete CE-marked SIRT solution including QuiremScout™, QuiremSpheres™ and the supporting dosimetry software Q-Suite™.
